Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-22-012382
Filing Date
2022-11-14
Accepted
2022-11-14 16:50:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 cmra-q3-2022_-_424b3_cs.htm 424B3 3257176
2 EX-31.1 cmra-ex31_1.htm EX-31.1 26852
3 EX-31.2 cmra-ex31_2.htm EX-31.2 26887
4 EX-32.1 cmra-ex32_1.htm EX-32.1 16873
5 EX-32.2 cmra-ex32_2.htm EX-32.2 17128
  Complete submission text file 0000950123-22-012382.txt   3345878
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267283 | Film No.: 221386952
SIC: 2834 Pharmaceutical Preparations